Arcutis Biotherapeutics (ARQT) Other Working Capital Changes (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Other Working Capital Changes of -$137000.0 for Q1 2026, up 31.5% year-over-year from -$104182.5 in Q1 2025, and up 90.37% quarter-over-quarter from -$1.4 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$137000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 31.5% year-over-year to -$137000.0; the TTM figure through Mar 2026 stood at -$617000.0 (down 109.82% YoY), while the FY2025 annual figure was -$680000.0, down 171.73% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$137000.0, up from -$1.4 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $9.1 million in Q4 2023, with the low at -$5.5 million in Q1 2024.
- The 5-year median for Other Working Capital Changes is -$137000.0 (2026), against an average of $489352.9.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes jumped 6173.33% in 2023, then sank 2254.55% in 2025.
- Arcutis Biotherapeutics' Other Working Capital Changes stood at -$150000.0 in 2022, then surged by 6173.33% to $9.1 million in 2023, then tumbled by 99.28% to $66000.0 in 2024, then tumbled by 2254.55% to -$1.4 million in 2025, then soared by 90.37% to -$137000.0 in 2026.
- Business Quant data shows ARQT's Other Working Capital Changes at -$137000.0 in Q1 2026, -$1.4 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.55 Mn |
| Jun 30, 2026 | 2.55 Mn |
| Jun 30, 2026 | 2.55 Mn |
| Mar 31, 2026 | -137,000.00 |
| Mar 31, 2026 | -137,000.00 |
| Mar 31, 2026 | -137,000.00 |
| Dec 31, 2025 | -1.42 Mn |
| Dec 31, 2025 | -1.42 Mn |
| Dec 31, 2025 | -1.42 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | -204,000.00 |
| Jun 30, 2025 | -204,000.00 |
| Jun 30, 2025 | -204,000.00 |
| Mar 31, 2025 | -200,000.00 |
| Mar 31, 2025 | -200,000.00 |
| Mar 31, 2025 | -200,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Dec 31, 2024 | 66,000.00 |